newsfilter
← Latest News
PR Newswire·

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Beta Bionics, Inc. to Contact Law Firm

  • Beta Bionics reported an unexpected shortfall in new iLet Bionic Pancreas patient starts on January 8, 2026.
  • The announcement followed a December 2025 report revealing an FDA Form 483 concerning the device.
  • Beta Bionics stock price fell $11.85 per share, or approximately 37%, to close at $20.14 on January 9, 2026.
  • On January 30, 2026, the company disclosed an FDA warning letter related to quality management, medical device reporting, & corrective actions.
  • The FDA publicly released the warning letter on February 24, 2026, mandating reporting of malfunctions causing death or serious injury, including resolved hypoglycemic episodes.
  • Fletcher Moore of Moore Law PLLC is seeking shareholder contact for potential claims regarding monetary damages, corporate governance reforms, reimbursement, & incentive awards.
  • Legal representation is offered on a contingency fee basis with no cost to shareholders.